05:30 PM EDT, 04/03/2025 (MT Newswires) -- AbbVie ( ABBV ) said Thursday it expects to report Q1 adjusted earnings of $2.34 to $2.38 per diluted share, reflecting an unfavorable impact of $0.13 per share from $248 million in acquired in-process research and development expenses and milestone payments.

Analysts polled by Factset, on average, are expecting $2.51.

The company said it now expects full-year 2025 adjusted earnings of $11.99 to $12.19 per share, down from its prior guidance of $12.12 to $12.32 issued in January.

Analysts are modeling for a $12.30 profit.